REXAHN PHARMACEUTICALS INC - COM (RNN)

CUSIP: 761640101

Q2 2015 13F Holders as of 30 Jun 2015

Type / Class
Equity / COM
Total 13F shares
8,823,296
Share change
+683,315
Total reported value
$5,360,000
Price per share
$0.61
Number of holders
32
Value change
+$409,934
Number of buys
11
Number of sells
8

Quarterly Holders Quick Answers

What is CUSIP 761640101?
CUSIP 761640101 identifies RNN - REXAHN PHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of REXAHN PHARMACEUTICALS INC - COM (RNN) as of Q2 2015

As of 30 Jun 2015, REXAHN PHARMACEUTICALS INC - COM (RNN) was held by 32 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 8,823,296 shares. The largest 10 holders included VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC, WELLS FARGO & COMPANY/MN, BlackRock Institutional Trust Company, N.A., CONDOR CAPITAL MANAGEMENT, HUDSON VALLEY INVESTMENT ADVISORS INC /ADV, NORTHERN TRUST CORP, BRIDGEWAY CAPITAL MANAGEMENT INC, and Northeast Financial Consultants Inc. This page lists 32 institutional shareholders reporting positions in this security for the Q2 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.